MYC and malignant colon neoplasm: MID1IP1 is an oncogene well-known as a negative regulator of AMP-activated protein kinase (AMPK), and our recent study has shown that knockdown of MID1IP1 can inhibit the expression of c-Myc in the growth of liver and colon cancer.